Re-Export of Alkaloids Not in Dosage Forms
This key economic indicator for the Pharmaceutical sector has been recently updated.
- United States increased 36.5% of Re-Export of Alkaloids Not in Dosage Forms in 2019, from a year earlier.
- Since 2014 United States Re-Export of Alkaloids Not in Dosage Forms jumped by 182.7% year on year totalising $465,437.
- In 2018 New Zealand was ranked number 3 in Re-Export of Alkaloids Not in Dosage Forms.
Top Countries in Re-Export of Alkaloids Not in Dosage Forms
# | 4 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
United States
|
465,437.00 | 2019 | +36.5 % | +182.7 % | View data |
2 |
#2
United Arab Emirates
|
8,794.32 | 2018 | NA | -56.8 % | View data |
3 |
#3
New Zealand
|
83.84 | 2018 | NA | -48.7 % | View data |
4 |
#4
Jamaica
|
51.00 | 2016 | NA | NA | View data |
Source: United Nations Statistical Office